Timo Sane

3.6k total citations
47 papers, 2.2k citations indexed

About

Timo Sane is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Timo Sane has authored 47 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Surgery and 12 papers in Molecular Biology. Recurrent topics in Timo Sane's work include Pituitary Gland Disorders and Treatments (13 papers), Neuroendocrine Tumor Research Advances (9 papers) and Adrenal and Paraganglionic Tumors (7 papers). Timo Sane is often cited by papers focused on Pituitary Gland Disorders and Treatments (13 papers), Neuroendocrine Tumor Research Advances (9 papers) and Adrenal and Paraganglionic Tumors (7 papers). Timo Sane collaborates with scholars based in Finland, United States and Germany. Timo Sane's co-authors include Esko A. Nikkilä, Marja‐Riitta Taskinen, Matti Välimäki, Tuula Pekkarinen, Pertti Mustajoki, Jarmo Kaukua, Risto Pelkonen, Ritva Kauppinen‐Mäkelin, Helene Markkanen and Pasi Salmela and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Timo Sane

47 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timo Sane Finland 26 1.4k 661 519 352 239 47 2.2k
Giorgio Borretta Italy 24 1.7k 1.2× 1.4k 2.1× 201 0.4× 308 0.9× 332 1.4× 87 2.7k
Sylvain Ricard France 21 1.8k 1.3× 686 1.0× 243 0.5× 847 2.4× 136 0.6× 31 4.0k
J. F. Henry France 20 684 0.5× 932 1.4× 180 0.3× 211 0.6× 196 0.8× 52 1.7k
Wojciech Zgliczyński Poland 23 1.3k 0.9× 502 0.8× 232 0.4× 207 0.6× 74 0.3× 170 1.9k
Dirk Weismann Germany 24 1.3k 0.9× 1.1k 1.6× 361 0.7× 422 1.2× 563 2.4× 50 2.4k
Omar Serri Canada 26 1.9k 1.4× 797 1.2× 514 1.0× 279 0.8× 47 0.2× 81 2.5k
Nadia Caraccio Italy 27 2.2k 1.5× 447 0.7× 181 0.3× 324 0.9× 56 0.2× 62 2.9k
Guy Touati France 33 1.1k 0.7× 571 0.9× 195 0.4× 1.4k 4.1× 111 0.5× 94 3.7k
Θεοδώρα Παππά United States 19 860 0.6× 362 0.5× 298 0.6× 194 0.6× 61 0.3× 61 1.4k
I. M. Holdaway New Zealand 24 1.6k 1.1× 738 1.1× 430 0.8× 843 2.4× 359 1.5× 98 3.8k

Countries citing papers authored by Timo Sane

Since Specialization
Citations

This map shows the geographic impact of Timo Sane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Sane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Sane more than expected).

Fields of papers citing papers by Timo Sane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timo Sane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Sane. The network helps show where Timo Sane may publish in the future.

Co-authorship network of co-authors of Timo Sane

This figure shows the co-authorship network connecting the top 25 collaborators of Timo Sane. A scholar is included among the top collaborators of Timo Sane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timo Sane. Timo Sane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leijon, Helena, Minna Soinio, Saara Metso, et al.. (2021). Characteristics and outcomes of the Finnish ectopic ACTH syndrome cohort. Endocrine. 74(2). 387–395. 10 indexed citations
2.
Pekkarinen, Tuula, Harri Mustonen, Timo Sane, et al.. (2016). Long-Term Effect of Gastric Bypass and Sleeve Gastrectomy on Severe Obesity: Do Preoperative Weight Loss and Binge Eating Behavior Predict the Outcome of Bariatric Surgery?. Obesity Surgery. 26(9). 2161–2167. 35 indexed citations
3.
Heiskanen, Ilkka, Timo Sane, Satu Maria Remes, et al.. (2014). Helsinki score—a novel model for prediction of metastases in adrenocortical carcinomas. Human Pathology. 46(3). 404–410. 81 indexed citations
5.
Itkonen, Outi, Timo Sane, Helene Markkanen, et al.. (2013). Analytical and preanalytical validation of a new mass spectrometric serum 5-hydroxyindoleacetic acid assay as neuroendocrine tumor marker. Clinica Chimica Acta. 428. 38–43. 46 indexed citations
6.
Louhimo, Johanna, et al.. (2013). Adrenocortical tumours: high CT attenuation value correlates with eosinophilia but does not discriminate lipid-poor adenomas from malignancy. Journal of Clinical Pathology. 66(12). 1076–1080. 6 indexed citations
7.
Schalin‐Jäntti, Camilla, L. Sylvia, Johanna Arola, & Timo Sane. (2012). Recurrent Acute-Onset Cushing’s Syndrome 6 Years after Removal of a Thymic Neuroendocrine Carcinoma: From Ectopic ACTH to CRH. Endocrine Pathology. 24(1). 25–29. 13 indexed citations
8.
Laitinen, Eeva‐Maria, Johanna Tommiska, Timo Sane, et al.. (2012). Reversible Congenital Hypogonadotropic Hypogonadism in Patients with CHD7, FGFR1 or GNRHR Mutations. PLoS ONE. 7(6). e39450–e39450. 52 indexed citations
9.
Honkasalo, Mikko, et al.. (2011). Severe hypoglycaemia in drug-treated diabetic patients needs attention: A population-based study. Scandinavian Journal of Primary Health Care. 29(3). 165–170. 20 indexed citations
10.
Heliövaara, Elina, Anniina Raitila, Virpi Launonen, et al.. (2009). The Expression of AIP-Related Molecules in Elucidation of Cellular Pathways in Pituitary Adenomas. American Journal Of Pathology. 175(6). 2501–2507. 48 indexed citations
11.
Schalin‐Jäntti, Camilla, Leena Valanne, Mikko Tenhunen, et al.. (2009). Outcome of fractionated stereotactic radiotherapy in patients with pituitary adenomas resistant to conventional treatments: a 5·25‐year follow‐up study. Clinical Endocrinology. 73(1). 72–77. 33 indexed citations
12.
Kauhanen, Saila, Marko Seppänen, Jari Ovaska, et al.. (2008). The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors. Endocrine Related Cancer. 16(1). 255–265. 62 indexed citations
13.
Kauhanen, Saila, Marko Seppänen, Heikki Minn, et al.. (2007). Fluorine-18-l-Dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography as a Tool to Localize an Insulinoma or β-Cell Hyperplasia in Adult Patients. The Journal of Clinical Endocrinology & Metabolism. 92(4). 1237–1244. 108 indexed citations
14.
Kauppinen‐Mäkelin, Ritva, Timo Sane, Harri Sintonen, et al.. (2006). Quality of Life in Treated Patients with Acromegaly. The Journal of Clinical Endocrinology & Metabolism. 91(10). 3891–3896. 81 indexed citations
15.
Kauppinen‐Mäkelin, Ritva, Timo Sane, Antti Reunanen, et al.. (2005). A Nationwide Survey of Mortality in Acromegaly. The Journal of Clinical Endocrinology & Metabolism. 90(7). 4081–4086. 207 indexed citations
16.
Sane, Timo, et al.. (2005). [Insulin pump in the treatment of adult age diabetes].. PubMed. 121(8). 839–45. 2 indexed citations
17.
Kaukua, Jarmo, Tuula Pekkarinen, Timo Sane, & Pertti Mustajoki. (2003). Sex Hormones and Sexual Function in Obese Men Losing Weight. Obesity Research. 11(6). 689–694. 163 indexed citations
18.
Tuomilehto, Jaakko, et al.. (2001). Voidaanko aikuisena sairastuneen tyypin 1diabeetikon insuliinihoito aloittaa polikliinisesti. 23. 2507–2511. 1 indexed citations
19.
Välimäki, Matti, et al.. (1991). Is the treatment of metastatic carcinoid tumor with interferon not as successful as suggested?. Cancer. 67(3). 547–549. 50 indexed citations
20.
Sane, Timo, Pertti Mustajoki, & Matti Välimäki. (1991). Insulin Therapy in Maturity-Onset Diabetes. Annals of Medicine. 23(1). 13–19. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026